wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

Plavix Training - Jan POA 2026

Total questions: 20

Worksheet time: 7mins

Name
Class
Date
1.

When should you start the winning combo of Plavix + Aspirin for stroke patients?

a)

Within 48 hours - Better late than never!

b)

Within 24 hours - Strike while the iron is hot!

c)

Within 72 hours - Slow and steady wins the race 

d)

Within 1 week - Good things come to those who wait

2.

HOST-EXAM proved Plavix monotherapy beats aspirin in the modern era. What does this reinforce? 

a)

CURE trial findings

b)

CAPRIE trial

c)

PLATO trial results

d)

TRITON trial data

3.

What's the TOPIC trial's recipe for post-ACS success?

a)

1 month potent DAPT, then 12 months Plavix DAPT

b)

12 months potent DAPT only

c)

6 months potent DAPT, then aspirin

d)

Lifelong potent DAPT

4.

TALOS-AMI showed switching from ticagrelor to Plavix DAPT gave superior net clinical benefit. What was the key win? 

a)

Lower cost

b)

Better compliance

c)

Significant decrease in bleeding risk with no increase in ischemic risk

d)

Faster onset of action 

5.

What makes East Asian patients special when it comes to antiplatelet therapy? 

a)

They need higher doses

b)

Higher bleeding risk + lower ischemic events

c)

They metabolize drugs faster

d)

They have better compliance

6.

When initiated within 24 hours after a minor stroke, the Plavix + ASA combo reduced stroke risk by approximately 

a)

15%

b)

22%

c)

32%

d)

45%

7.

The CAPRIE trial showed Plavix monotherapy was superior to aspirin by what relative risk reduction?

a)

12.5%

b)

20.1%

c)

5.2%

d)

8.7%

8.

Plavix has maintained its position as one of the most prescribed antiplatelet medications because:

a)

It's the newest option available

b)

It's the only option covered by insurance

c)

It works through multiple pathways

d)

It has the balance of efficacy, safety, and evidence

9.

If Plavix were a superhero, its superpower would be:

a)

Super strength (highest potency) 

b)

Invisibility (fewest side effects)

c)

Perfect balance (optimal efficacy/safety ratio)

d)

Mind reading (works for all patients)

10.

What makes Plavix stand out from newer P2Y12 inhibitors in many clinical scenarios? 

a)

It's the most expensive option

b)

It has the most robust long-term safety data

c)

It has the fastest onset of action

d)

It requires no monitoring 

11.

What makes Plavix (clopidogrel) different from aspirin in its mechanism?

a)

It inhibits thromboxane production

b)

It blocks the P2Y12 receptor on platelets

c)

It dissolves existing clots

d)

It reduces inflammation only

12.

What gives Plavix an advantage over more potent P2Y12 inhibitors in many patients?

a)

Lower bleeding risk

b)

No need for monitoring

c)

Once-weekly dosing

d)

No drug interactions

13.

If antiplatelet medications were at a party, Plavix would be: 

a)

The flashy newcomer showing off

b)

The party host who invited everyone

c)

The mysterious stranger in the corner

d)

The reliable friend everyone trusts

14.

Which of these is NOT an approved indication for Plavix?

a)

Recent MI 

b)

Recent stroke

c)

Atrial fibrillation

d)

Peripheral arterial disease 

15.

Which genetic variant affects Plavix metabolism?

a)

CYP2D6

b)

CYP3A4

c)

CYP2C19

d)

VKORC1

16.

How long does Plavix's antiplatelet effect last after you stop taking it?

a)

24 hours

b)

2-3 days

c)

5-7 days

d)

14 days

17.

What's the standard loading dose of Plavix in acute coronary syndrome

a)

75 mg

b)

100 mg

c)

300 mg

d)

400 mg

18.

What makes Plavix stand out in real-world clinical practice compared to newer agents?

a)

It works faster than all competitors

b)

It has no contraindications

c)

It's the cheapest option

d)

Decades of safety data + proven adherence

19.

Which trial supports using Plavix monotherapy instead of aspirin after PCI?

a)

CURE

b)

PLATO

c)

POINT

d)

HOST-EXAM

20.

Plavix can be safely combined with proton pump inhibitors without any concerns

a)

TRUE

b)

FALSE - Some PPIs reduce Plavix effectiveness